iCeutica, a Philadelphia biotech looking to “repackage” drugs in nanotechnology formulations that may improve their safety or effectiveness, raised $1.1 million in a second funding round, VentureWire reports (subscription required). Nordic Biotech and individual investors provided the funding.


VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform
  • networking features, and more
Become a member